Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ursula Matulonis

28PUBLICATIONS
247CO-AUTHORS
ChemotherapyOncology and carcinogenesis not elsewhere classifiedMolecular targetsPacific Peoples theory of change models for healthEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

Sort by Publication Date:
|Mar 11, 2026
What does the future hold for antibody-drug conjugate therapies in ovarian cancer?

Page C Widick, Ursula A Matulonis, Meghan Shea

|Jul 23, 2025
Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without <i>BRCA</i> Mutation.

Panagiotis A Konstantinopoulos, Jae Weon Kim, Gilles Freyer

|Apr 10, 2025
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.

Panagiotis A Konstantinopoulos, Mingyang Cai, Elizabeth K Lee

|Mar 10, 2025
Usability, Acceptability, and Barriers to Implementation of a Collaborative Agenda-Setting Intervention (CASI) to Promote Person-Centered Ovarian Cancer Care: Development Study.

Rachel A Pozzar, James A Tulsky, Donna L Berry

|Feb 20, 2025
Smartphone-based measures as real-world indicators of functional status in advanced cancer patients.

Marcin Straczkiewicz, Nancy L Keating, Stephanie M Schonholz

|Feb 11, 2025
Functional Profiling of p53 and RB Cell Cycle Regulatory Proficiency Suggests Mechanism-Driven Molecular Stratification in Endometrial Carcinoma.

Zelei Yang, Saie Mogre, Hyeji Jun

Pageof 5

Frequent Collaborators

7 joint publications

Panagiotis A Konstantinopoulos

6 joint publications

Domenica Lorusso

6 joint publications

Joyce F Liu

5 joint publications

Madeline Polak

5 joint publications

Alexi A Wright

5 joint publications

Toon Van Gorp

5 joint publications

Ana Oaknin

4 joint publications

Bradley J Monk

4 joint publications

Nicoletta Colombo

4 joint publications

Richard T Penson

Frequent Collaborators

7 joint publications

Panagiotis A Konstantinopoulos

6 joint publications

Domenica Lorusso

6 joint publications

Joyce F Liu

5 joint publications

Madeline Polak

Top Related Videos

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on : May 16, 2020

6.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.4K
See more related videos

Top Related Videos

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on : May 16, 2020

6.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.4K
See more related videos